Embracing Highly Effective Obesity Therapies to Improve Cancer Treatment and Survivorship

JAMA Oncology 2026

View at publisher

Authors: Ryan Howard, Melissa Pilewskie, Lesly A. Dossett

DOI: 10.1001/jamaoncol.2026.0260

Cited by: 2

References: 7

Abstract

This Viewpoint examines the underutilization of glucagon-like peptide-1 receptor agonists and bariatric surgery in survivors of cancer.

Diabetes Treatment and Management Bariatric Surgery and Outcomes Metabolism Diabetes and Cancer

References 7